National and State-Specific Estimates of Settings of Receiving Human Papillomavirus Vaccination Among Adolescents in the United States
- PMID: 33867229
- PMCID: PMC9080285
- DOI: 10.1016/j.jadohealth.2021.03.005
National and State-Specific Estimates of Settings of Receiving Human Papillomavirus Vaccination Among Adolescents in the United States
Abstract
Purpose: Human papillomavirus (HPV) vaccination in the United States has been recommended for girls since 2006 and for boys since 2011. However, settings of receiving HPV vaccination have not been assessed. The purpose of this study is to assess settings of receiving HPV vaccination among adolescents in order to understand what strategies are needed to improve vaccination uptake.
Methods: Data from the 2018 National Immunization Survey-Teen (NIS-Teen) were analyzed to assess place of HPV vaccination overall, and by gender, quarter, and other selected variables among adolescents in the United States. The 2016-2018 NIS-Teen data were combined to assess state-specific place of HPV vaccination.
Results: Among vaccinated adolescents aged 13-17 years, a doctor's office was the most common place where HPV vaccination was received (79.2%), followed by clinics, health centers, or other medical facilities (13.5%), health department (4.1%), hospital or emergency room (2.3%), schools (.5%), and pharmacies or stores (.4%). Overall, 99.1% of adolescents aged 13-17 years received HPV vaccination at medical settings and only .9% at nonmedical settings. Reported vaccination in nonmedical settings by state ranged from less than .1% in Delaware, Florida, and New Hampshire to 4.1% in North Dakota, with a median of 1.0%.
Conclusions: Doctor's offices were the most common medical setting for adolescents to receive HPV vaccination. Less than 1% of adolescents received vaccination at nonmedical settings. Continuing work with medical and nonmedical settings to identify and implement appropriate strategies are needed to improve HPV vaccination coverage among adolescents.
Keywords: Adolescents; Coverage; Human papillomavirus (HPV) vaccine; Medical settings; National Immunization Survey-Teen (NIS-Teen); Nonmedical settings; Place of vaccination; Vaccination.
Published by Elsevier Inc.
Conflict of interest statement
Conflict of Interest Statement: All authors have no conflicts of interest to be stated.
Similar articles
-
Trends in human papillomavirus (HPV) vaccination initiation among adolescents aged 13-17 by metropolitan statistical area (MSA) status, National Immunization Survey - Teen, 2013 - 2017.Hum Vaccin Immunother. 2020 Mar 3;16(3):554-561. doi: 10.1080/21645515.2019.1671765. Epub 2019 Oct 29. Hum Vaccin Immunother. 2020. PMID: 31662024 Free PMC article.
-
Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):620-4. MMWR Morb Mortal Wkly Rep. 2014. PMID: 25055185 Free PMC article.
-
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020.MMWR Morb Mortal Wkly Rep. 2021 Sep 3;70(35):1183-1190. doi: 10.15585/mmwr.mm7035a1. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34473682 Free PMC article.
-
Strategies to improve human papillomavirus vaccination rates among adolescents in family practice settings in the United States: A systematic review.J Clin Nurs. 2021 Feb;30(3-4):341-356. doi: 10.1111/jocn.15579. Epub 2020 Dec 16. J Clin Nurs. 2021. PMID: 33270305
-
National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation.Vaccine. 2022 Mar 31;40 Suppl 1(Suppl 1):A2-A9. doi: 10.1016/j.vaccine.2021.04.025. Epub 2021 May 4. Vaccine. 2022. PMID: 33962839 Free PMC article. Review.
Cited by
-
Trends in adolescent COVID-19 vaccination receipt and parental intent to vaccinate their adolescent children, United States, July to October, 2021.Ann Med. 2022 Dec;54(1):733-742. doi: 10.1080/07853890.2022.2045034. Ann Med. 2022. PMID: 35238263 Free PMC article.
-
HPV vaccination and factors influencing vaccine uptake among people of Indian ancestry living in the United States.Epidemiol Infect. 2022 Jul 27;150:e152. doi: 10.1017/S0950268822001315. Epidemiol Infect. 2022. PMID: 35894243 Free PMC article.
-
Human papillomavirus vaccine administration opportunities at well visits in adolescents.BMC Public Health. 2025 Jun 4;25(1):2084. doi: 10.1186/s12889-025-23235-9. BMC Public Health. 2025. PMID: 40468233 Free PMC article.
-
HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US.Hum Vaccin Immunother. 2023 Dec 31;19(1):2161253. doi: 10.1080/21645515.2022.2161253. Epub 2023 Jan 11. Hum Vaccin Immunother. 2023. PMID: 36631995 Free PMC article.
References
-
- Satterwhite CL, Torrone E, Meites E, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis 2013;40(3):187–193. - PubMed
-
- Centers for Disease Control and Prevention (CDC). Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2007;56(RR-2):1–24. - PubMed
-
- Centers for Disease Control and Prevention (CDC). Recommendations on the use of quadrivalent human papillomavirus vaccine in males — Advisory Committee on Immunization Practices (ACIP), 2011. MMWR 2011;60(50):1705–1708. - PubMed
-
- Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination — updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2016;65(49):1405–8. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical